Delayed Graft Function clinical trials

The registry lists 83 studies for Delayed Graft Function across more than 10 countries. 15 are recruiting or about to start. 64 of them are mainly about Delayed Graft Function (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Delayed Graft Function studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 32
Status unknown: 18
Terminated: 11
Recruiting: 8
Not yet recruiting: 7
Withdrawn: 4

Phase

Phase 2: 18
Phase 4: 15
Phase 3: 14
Phase 1: 10
Early Phase 1: 1

Where

United States: 37
France: 11
Spain: 10
China: 10
Canada: 8
Germany: 7

Who runs them

Angion Biomedica Corp (3) · University of Wisconsin, Madison (3) · First Affiliated Hospital Xi'an Jiaotong University (3) · Y's Therapeutics, Inc. (3) · Nantes University Hospital (2) · Quark Pharmaceuticals (2) · Alexion Pharmaceuticals, Inc. (2) · Rhode Island Hospital (1)

What is being tested here

Drugs under test in Delayed Graft Function studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Furosemide	1	0	3
Mannitol	1	0	1
Ravulizumab	1	1	1
Treprostinil	1	0	1
Vonoprazan	1	0	1
Oxygen	1	1	1
Abatacept	0	0	4
Eculizumab	0	1	3
Everolimus	0	1	3
Mycophenolic Acid	0	0	3

Drug classes tested here mTOR inhibitors 5 · Calcineurin inhibitors 3

Coming up

2phase 3 studies under way

4studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4, phase 3 first

Nov 2027Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation · Phase 3 · Alexion Pharmaceuticals, Inc.
Jun 2027Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage · Vanderbilt University Medical Center
Jul 2027Drone Transport of Deceased-Donor Kidney Grafts Between Two French Hospitals Before Transplantation: a Pilot Safety Study · Nantes University Hospital
Nov 2027Collapsibility Index of the Inferior Vena Cava and Kidney Transplantation · CHU de Reims

Who these studies take

Of the 8 Delayed Graft Function studies recruiting now, 7 (88%) set no upper age limit and 1 (13%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 8
Age	Women	Men
10	0 (0%)	0 (0%)
18	8 (100%)	8 (100%)
30	8 (100%)	8 (100%)
40	8 (100%)	8 (100%)
50	8 (100%)	8 (100%)
65	8 (100%)	8 (100%)
75	8 (100%)	8 (100%)
85	7 (88%)	7 (88%)

Across all 83 studies, recruiting or not: 23% stop at 75 or younger and 8% at 65; 12% take children; 0% are for women only and 1% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Bioimpedance and Multiparametric Ultrasound-Guided Fluid Management After Kidney TransplantationOct 30, 2026NCT07905963

Studies

Recruiting first, then most recently updated. Showing 50 of 83. Browse all 83 → or search them.